What factors affect sufficient dosing orlistat?
Orlistat, sometimes called tetrahydrolipstatin, is a drug for weight loss, which is classified as an inhibitor of lipase. Lipase inhibitors prevent certain enzymes called lipases, in the digestion of complex fats in the body. The body then removes these fats in their complete form rather than breaks them and allows them to absorb them. Unlike many drugs that have many potential doses based on the condition of the person who takes them, the only dose of orlists is used for most people. However, there are slight differences in dosing mode, but they can affect how often it is taken. It can be accepted up to three times a day, once with each meal, within an hour after a meal. Missing food or eating food without fat means that the dose can be skipped without adverse consequences. In scientific evidence. Research conducted by GlaxosmithKline, one of the manufacturers of this drug, has shown that higher doses do not provide any other benefits. This amount of drugs removes almost a third of the fat from food.
In addition to the prescribed medicine, this medicine can also be purchased as an over -the -counter formulation, but at a different dose. Usually, a dose of orlistat 60 mg is used when administering a drug without a prescription. Like the prescription version of this carpet, the OTC form is collected around meals, a maximum of three times a day.
Most people who use Orlistat for weight loss do not develop serious side effects, even if there are exceptions. The therapeutic doses of this drug also have certain potential risks. The most common is vitamin depletion, because some vitamins that normally absorb into the body of the fat cell can be excreted by this drug. Use of vitamin supplements can help prevent this phenomenon.
Orlistat dosage may not be modified according to conditions affecting the renal system or kidneys because it does not leave the body urine. However, kidney damage may sometimes result from the use of this drug as it can cause harmful chemicals called oxalEat moves from the gastrointestinal (GI) tract to the kidneys. Occasionally, liver damage may also result from the reception of orlists, although this organ is not metabolized.